Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Operating Margin (2016 - 2026)

Biomerica's Operating Margin history spans 17 years, with the latest figure at 131.51% for Q1 2026.

  • On a quarterly basis, Operating Margin fell 2338.0% to 131.51% in Q1 2026 year-over-year; TTM through Feb 2026 was 123.74%, a 16803.0% decrease, with the full-year FY2025 number at 96.72%, down 11975.0% from a year prior.
  • Operating Margin hit 131.51% in Q1 2026 for Biomerica, down from 113.47% in the prior quarter.
  • Over the last five years, Operating Margin for BMRA hit a ceiling of 545.34% in Q2 2024 and a floor of 208.81% in Q2 2025.
  • Historically, Operating Margin has averaged 70.17% across 5 years, with a median of 108.13% in 2025.
  • Biggest five-year swings in Operating Margin: soared 71104bps in 2024 and later plummeted -75415bps in 2025.
  • Tracing BMRA's Operating Margin over 5 years: stood at 112.42% in 2022, then grew by 9bps to 102.62% in 2023, then soared by 41bps to 60.7% in 2024, then tumbled by -87bps to 113.47% in 2025, then fell by -16bps to 131.51% in 2026.
  • Business Quant data shows Operating Margin for BMRA at 131.51% in Q1 2026, 113.47% in Q4 2025, and 81.01% in Q3 2025.